The clock’s ticking on Stelara: Amgen, J&J ink patent settlement esagonowsky Tue, 05/23/2023 – 17:08 More: The clock's ticking on Stelara: Amgen, J&J ink patent settlement Source: fierce
read moreIndivior’s Opvee crosses FDA finish line, adding new overdose rescue option amid raging opioid epidemic zbecker Tue, 05/23/2023 – 12:09 More: Indivior's Opvee crosses FDA finish line, adding new overdose rescue option amid raging opioid epidemic Source: fierce
read moreAmid high-profile injectable launch, Novo Nordisk scores with its pill version of obesity drug Wegovy kdunleavy Tue, 05/23/2023 – 10:34 More: Amid high-profile injectable launch, Novo Nordisk scores with its pill version of obesity drug Wegovy Source: fierce
read moreIn strategic pivot under new CEO Francis, Teva plots cuts to its generics portfolio zbecker Tue, 05/23/2023 – 09:16 More: In strategic pivot under new CEO Francis, Teva plots cuts to its generics portfolio Source: fierce
read moreVital financing will allow the company to build a pipeline of novel therapies targeting serious conditions More: Scarlet Therapeutics gains funding for blood cell platform Source: News
read moreReceptor antagonist AM1476 developed as an anti-fibrotic treatment for lung and skin disorders More: Positive data for AnaMar’s fibrosis therapy Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals